AmplyCell

[AmplyCell @AmplyCell]

Événement le 18 septembre : Journée dédiée aux biobanques et la nouvelles réglementation belge. De nombreux spécialistes du secteurs y participent, voir agenda! https://t.co/ceb8ic3IxN

[AmplyCell @AmplyCell]

Trump signs bill giving terminally ill patients 'right to try' experimental drugs https://t.co/jwEQ8bxthu

[AmplyCell @AmplyCell]

Fujifilm pays $800m for cell culture media firm Irvine Scientific https://t.co/pA5le7n8rS

[AmplyCell @AmplyCell]

Research & Development & Commercialization, this is the challenge to adress... At the quickest! https://t.co/AYXnLE7DP1

[AmplyCell @AmplyCell]

CDMOs need to adapt to changing industry, reevaluate outlook and partnering models https://t.co/7AFLoIUMEU

[AmplyCell @AmplyCell]

... And we have all those ingredients at AmplyCell! <3 https://t.co/jOrLUIScf0

[AmplyCell @AmplyCell]

New impressive labs close to Liège! https://t.co/xUxWbYm4tE

[AmplyCell @AmplyCell]

Univercells keeps on going forward to reach it's mission... Biologics afordable to all! https://t.co/2nkiWr0wgi

[AmplyCell @AmplyCell]

Amplycell is part of BIO-Europe again! Let's talk about decreasing biomanufacturing CoG thanks to our AMPLY... https://t.co/ATYLLFo5qY

[AmplyCell @AmplyCell]

Nice results for Tocilizumab! https://t.co/XPzWFIL7lp

[AmplyCell @AmplyCell]

Plan as early as possible. https://t.co/b3H3yce3Fw

[AmplyCell @AmplyCell]

FDA issues draft guidance on statistical approaches to evaluating similarity for biosimilars https://t.co/zMiYEdKYeS

[AmplyCell @AmplyCell]

New acquisition for #Lonza that say "there is an increased demand for clinical-stage mammalian cell culture-based... https://t.co/Szl7qAL1vy

[AmplyCell @AmplyCell]

Tthe number of approved #biosimilars continues to grow! https://t.co/iFGiqBJu7U

[AmplyCell @AmplyCell]

Is CHO the future of Biomanufacturing? All other paltform have their chance! https://t.co/9825kJh1la

[AmplyCell @AmplyCell]

Manufacturing scale-up challenges in viral vector production... https://t.co/6MhvdfKnRp

[AmplyCell @AmplyCell]

Novel biologics development space, together with #SamsungBioepis and #Takeda https://t.co/2vylKDjbVf

[AmplyCell @AmplyCell]

What does "minor change to biologic production process" mean for FDA https://t.co/D6ejhz3am4

[AmplyCell @AmplyCell]

What do you think about an "open source" cell line?
By Jamie and our partner, Horizon Discovery https://t.co/c2v2zDSkWi

[AmplyCell @AmplyCell]

There are more and more opportunities in #bioprocessing positions! https://t.co/j2zzcQhffv